Professor David Bowtell has an extensive background in human cancer genomics. He is Principal Investigator for the Australian Ovarian Cancer Study (AOCS), one of the largest population-based cohort studies of ovarian cancer in the world involving over 3000 women. He is a Fellow of the Australian Academy of Health and Medical Sciences and the Australian Academy of Science. He was Director of Research at Peter Mac for a decade from 2000-2009.

Professor Bowtell’s research has made major contributions to the molecular classification of ovarian cancer, the identification of therapeutic targets including cyclinE1, acquired drug resistance, the genomics of high grade serous ovarian cancer and long-term survival. His current research is focused on exceptional survivors and early-stage clinical trials in ovarian cancer.